The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study

An increasing number of gastrointestinal cancer (GI) patients suffer from side effects of cancer treatment that can affect their mood states and quality of life. Despite its demonstrated effectiveness in female cancer patients, Supportive Expressive Group Therapy (SEGT) has not been tested in male cancer patients. The current study sought to examine the longitudinal effects of a professionally-led, men-only SEGT on mood states, coping, and quality of life (QoL) in male GI cancer patients.

Read the full article here. 

Oberoi, D., Martopullo, C., Bultz, B. D., & Carlson, L. E. (2021). The effectiveness of a men-only supportive expressive group therapy intervention for psychosocial health outcomes in gastrointestinal cancer patients: a 6-month longitudinal study. Health and Quality of Life Outcomes, 19(1), 1-14.

SUPPORT SERVICES: 

Cancer Council 13 11 20

A free confidential telephone support service in each state and territory

Like many conditions, cancer affects propertionally higher rates of males than females. Understanding the major risk factors for cancer to bring about effective prevention and treatment is useful for services.

It is important to understand the prevalence of cancers among males as death from cancer is the next most pressing cause after cardiovascular disease.

For cancer advice and awareness information directed at males, these resources may provide useful guidance.

For individuals and organisations running events or creating awareness about the experiences of men and boys with cancer, it can be useful to have access toresources designed for males.

This report is a summary of the presentations and debate at the Men and Cancer Expert Roundtable in January, 2013, King's Fund, London, UK. Men are over 35% more likely to die from cancer than women in the UK. This difference is even more evident when breast cancer and sex-specific cancers such as prostate and ovarian are removed from the analysis – men were then 67% more likely to die from cancer.

This resource has been produced to provide men with advanced prostate cancer an in-depth guide to its treatment and management.

Being diagnosed with cancer comes as a shock to every patient. What follows is often a deluge of confusing information, mixed views on the treatment options and general confusion and uncertaintiy for the patient and their family.

Published in the Journal Of Men's Health in May 2011, this reviewed strategies to engage men in lung cancer screening.

 "Focus on strategies that work rather than strategies that put men off seeking help..."

Traditionally, many men have not been proactive about their prostate health. They have seen prostate cancer as a disease that old men die with, not of. Unfortunately, the statistics tell a very different story.

Prostate cancer is the most common cancer diagnosed in Australia, with almost 20,000 men diagnosed each year. Australia and New Zealand have the highest incidence in the world, with one in seven men diagnosed by age 75 and one in five diagnosed by age 85.

Community awareness of prostate cancer has increased markedly in the last ten years. This offers some useful insights into men's and women's perspectives on prostate cancer.

Prostate cancer is viewed as being the major men's health issue and one of the top five health issues in the community although it accounts for 4.2% of male deaths and 13% of male cancer deaths.

This resource has been developed for General Practitioners to assist with the early detection of prostate cancer in a way that encourages discussion with male patients.

This guide can help a GP provide easy to understand information to a man about prostate cancer screening and the likelihood of being diagnosed with prostate cancer.

The PCFA Ambassador Program’s objective is to raise community awareness of prostate cancer and to provide resources for individuals to learn more. Ambassador presentations are delivered by trained people, many of whom have first-hand experience of prostate cancer. Around 3,300 men a year die from prostate cancer in Australia.

This document recognises that some men with testicular cancer will experience ongoing anxiety and depression, and that managing these states is an important part of the journey towards healing.

Helping men work through the process of receiving treatment for cancer includes managing their emotional and social wellbeing as much as their physical health.

The Prostate Cancer Health Outcomes Research Unit (PCHORU), supported by the Movember Foundation, has established and analysed data from the Prostate Cancer Outcomes Registry – Australia and New Zealand to address some of the unmet needs of men with prostate cancer. 

"A key component of this global initiative has been the support for introducing prostate cancer outcomes registries to monitor patient-reported outcomes and patterns of care."

The NSW Cancer Institute provides data sources and portals to supply information about the rates of cancer in NSW in males. A male in Australia is 1.5 times more likely to be diagnosed with cancer than a female.